Summary
- Current Price
- As of today, QNCX price is $34.04, up +5.03% on
- Current Price All-Time High
- QNCX price is currently -97.21% below its historical high of $1,219.80 set on
- Market Cap
- QNCX current market cap is $35M, up +668.65% over the past 365 days
- Revenue
- QNCX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for QNCX has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Quince Therapeutics, Inc. |
| Ticker | NASDAQ: QNCX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | quincetx.com |
| Employees | 36 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $34.04 | ||
| Price, 1D Change | +5.03% | |
| $35M | ||
| - | ||
| - | ||
| 10.49 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$335.27 | ||
| EPS, 1Y Change | -27.62% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | CRTX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$335.27 | ||
| EPS Estimate | -$1.48 | N/A |
| EPS Est. Change | +99.56% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| $34.04 | ||
| Price Target | $81.00 | - |
| Price Tgt. Change | +137.96% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.17 | -$262.71 | -22,354.19% | |
| -$1.16 | -$335.27 | -28,927.36% | |
| -$1.48 | N/A | +99.56% | |
| -$5.76 | N/A | +98.28% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| +102.62% | ||
| +174.52% | ||
| +668.65% | ||
| -92.31% | ||
| 0.00% | ||
| 0.00% | ||
| -27.62% | ||
| -21,639.46% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $34.04 | ||
| $13.93 | ||
| $16.84 | ||
| $13.19 | ||
| $18.76 | ||
| $4.55 | ||
| 10.49 | ||
| $2.15 | ||
| 92.67 | ||
| 43.10% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$335.27 | ||
| $0.00 | ||
| - | ||
| -$50.43M | ||
| - | ||
| -$83.98M | ||
| - | ||
| -$50.29M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| -0.52 | ||
| 0.53 | ||
| 0.53 | ||
| - | ||
| - | ||
| -6.98 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 2.21 | ||
| -0.35 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| -$35.71M | ||
| $17.75M | ||
| $93.63M | ||
| $22.90M | ||
| $129.35M | ||
| $43.23M | ||
| $18.47M | ||
| $18.14M | ||
| $2.22M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $83.98M | ||
| $50.29M | ||
| $142.00K | ||
| $15.05M | ||
| $142.00K | ||
| $0.00 | ||
| $3.21M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$41.43M | ||
| $23.23M | ||
| $17.91M | ||
| $352.00K | ||
| -$41.78M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Oppenheimer | → | |
| Leerink Partners | ||
| Cantor Fitzgerald | ||
| D. Boral Capital | → | |
| Citizens | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → | |
| D. Boral Capital | → |
Analyst sentiment
Institutional ownership
Screeners with QNCX
FAQ
- What is the ticker symbol for Quince Therapeutics, Inc.?
- The ticker symbol for Quince Therapeutics, Inc. is NASDAQ:QNCX
- Does Quince Therapeutics, Inc. pay dividends?
- No, Quince Therapeutics, Inc. does not pay dividends
- What sector is Quince Therapeutics, Inc. in?
- Quince Therapeutics, Inc. is in the Healthcare sector
- What industry is Quince Therapeutics, Inc. in?
- Quince Therapeutics, Inc. is in the Biotechnology industry
- What country is Quince Therapeutics, Inc. based in?
- Quince Therapeutics, Inc. is headquartered in United States
- When did Quince Therapeutics, Inc. go public?
- Quince Therapeutics, Inc. initial public offering (IPO) was on May 9, 2019
- Is Quince Therapeutics, Inc. in the S&P 500?
- No, Quince Therapeutics, Inc. is not included in the S&P 500 index
- Is Quince Therapeutics, Inc. in the NASDAQ 100?
- No, Quince Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Quince Therapeutics, Inc. in the Dow Jones?
- No, Quince Therapeutics, Inc. is not included in the Dow Jones index
- When was Quince Therapeutics, Inc. last earnings report?
- Quince Therapeutics, Inc.'s most recent earnings report was on August 14, 2026
- When does Quince Therapeutics, Inc. report earnings?
- The date for Quince Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- QNCX Official Website www.quincetx.com
- QNCX Profile on Yahoo Finance finance.yahoo.com/quote/QNCX
- QNCX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/qncx